Scott Fidel
Stock Analyst at Stephens & Co.
(2.06)
# 2,905
Out of 5,090 analysts
185
Total ratings
43.75%
Success rate
-1.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Maintains: Overweight | $21 → $17 | $8.79 | +93.40% | 7 | Nov 14, 2025 | |
| CI The Cigna Group | Maintains: Buy | $370 → $330 | $265.44 | +24.32% | 14 | Nov 4, 2025 | |
| CNC Centene | Maintains: Sell | $33 → $38 | $38.34 | -0.89% | 12 | Oct 31, 2025 | |
| HCA HCA Healthcare | Maintains: Buy | $470 → $520 | $486.70 | +6.84% | 11 | Oct 27, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $207 → $167 | $151.86 | +9.97% | 11 | Oct 24, 2025 | |
| UHS Universal Health Services | Assumes: Neutral | $219 | $231.08 | -5.23% | 11 | Oct 14, 2025 | |
| THC Tenet Healthcare | Assumes: Buy | $224 | $210.00 | +6.67% | 11 | Oct 14, 2025 | |
| OSCR Oscar Health | Initiates: Neutral | $17 | $16.77 | +1.37% | 1 | Oct 14, 2025 | |
| ELV Elevance Health | Initiates: Neutral | $343 | $330.75 | +3.70% | 4 | Oct 14, 2025 | |
| ALHC Alignment Healthcare | Initiates: Buy | $21 | $19.55 | +7.42% | 6 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $91 | $75.63 | +20.32% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $406 | $330.91 | +22.69% | 23 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $142 | $113.19 | +25.45% | 12 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $38 | $29.12 | +30.49% | 18 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $48 → $31 | $30.76 | +0.78% | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $177.97 | -6.16% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $29.76 | -29.44% | 1 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $257.85 | -3.04% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $112.50 | -6.67% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $15.47 | +494.70% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $9.31 | -83.89% | 3 | Nov 11, 2022 |
Ardent Health
Nov 14, 2025
Maintains: Overweight
Price Target: $21 → $17
Current: $8.79
Upside: +93.40%
The Cigna Group
Nov 4, 2025
Maintains: Buy
Price Target: $370 → $330
Current: $265.44
Upside: +24.32%
Centene
Oct 31, 2025
Maintains: Sell
Price Target: $33 → $38
Current: $38.34
Upside: -0.89%
HCA Healthcare
Oct 27, 2025
Maintains: Buy
Price Target: $470 → $520
Current: $486.70
Upside: +6.84%
Molina Healthcare
Oct 24, 2025
Maintains: Neutral
Price Target: $207 → $167
Current: $151.86
Upside: +9.97%
Universal Health Services
Oct 14, 2025
Assumes: Neutral
Price Target: $219
Current: $231.08
Upside: -5.23%
Tenet Healthcare
Oct 14, 2025
Assumes: Buy
Price Target: $224
Current: $210.00
Upside: +6.67%
Oscar Health
Oct 14, 2025
Initiates: Neutral
Price Target: $17
Current: $16.77
Upside: +1.37%
Elevance Health
Oct 14, 2025
Initiates: Neutral
Price Target: $343
Current: $330.75
Upside: +3.70%
Alignment Healthcare
Oct 14, 2025
Initiates: Buy
Price Target: $21
Current: $19.55
Upside: +7.42%
Oct 14, 2025
Initiates: Buy
Price Target: $91
Current: $75.63
Upside: +20.32%
Oct 14, 2025
Initiates: Buy
Price Target: $406
Current: $330.91
Upside: +22.69%
Mar 12, 2025
Reiterates: Overweight
Price Target: $142
Current: $113.19
Upside: +25.45%
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $29.12
Upside: +30.49%
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $30.76
Upside: +0.78%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $177.97
Upside: -6.16%
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $29.76
Upside: -29.44%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $257.85
Upside: -3.04%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $112.50
Upside: -6.67%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $15.47
Upside: +494.70%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $9.31
Upside: -83.89%